Key result
Chronic kidney disease and end-stage renal disease were associated with a significant progressive upregulation in mean concentrations of inflammatory biomarkers compared to controls.
Why the study?
Are inflammatory biomarkers progressively upregulated in patients with chronic kidney disease and end-stage renal disease compared to age-matched controls?
Observational
Are inflammatory biomarkers progressively upregulated in patients with chronic kidney disease and end-stage renal disease compared to age-matched controls?
Inflammatory biomarkers progressively increase with worsening kidney disease, which may help evaluate the underlying inflammatory state and potential cardiovascular risk.
Answers are grounded in this paper and cite their sources.
May inform inflammatory assessment in CKD/ESRD; hypothesis-generating for CV risk, prospective studies needed before practice change.
Chronic kidney disease (CKD) has reached epidemic levels. It is a multisystem disease associated with elevated systemic inflammatory and hypercoagulable states. Most concerning are the cardiovascular risks associated with all stages of kidney disease. It is difficult to assess kidney disease stage progression and cardiovascular risk with current indicators such as estimated glomerular filtration rate and conventional cardiovascular risk factors. However, the use of biomarkers to assess the underlying pathological disease state may bridge the gap. This study evaluated biomarkers of inflammation including C-reactive protein, d-dimer, neuron-specific enolase, neutrophil gelatinase-associated lipocalin, tumor necrosis factor receptor I, and thrombomodulin in 3 groups of patients: CKD stages 2-4, end-stage renal disease (ESRD), and age-matched controls. The study demonstrated a statistically significant progressive upregulation in mean concentration of all markers when comparing controls to CKD and ESRD. Therefore, biomarkers may be able to evaluate the inflammatory state in kidney disease and potentially predict the cardiovascular risk.
No takes yet. Share an insight, caveat, or question.
Sharain et al. (2012) conducted an observational in Chronic Kidney Disease and End-Stage Renal Disease. Chronic kidney disease and end-stage renal disease vs. Age-matched controls was evaluated on Mean concentration of inflammatory biomarkers (C-reactive protein, d-dimer, neuron-specific enolase, neutrophil gelatinase-associated lipocalin, tumor necrosis factor receptor I, and thrombomodulin). Chronic kidney disease and end-stage renal disease were associated with a significant progressive upregulation in mean concentrations of inflammatory biomarkers compared to controls.
Synapse has enriched 10 related papers. Consider them for comparative context: